Cargando…

Large-scale identification of tissue-specific enhancers in vivo

Detalles Bibliográficos
Autor principal:	Pennacchio, Len A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026221/ http://dx.doi.org/10.1186/gb-2010-11-s1-i7

Ejemplares similares

Soft tissue handling and dental implant treatment
por: Neukam, Friedrich Wilhelm
Publicado: (2012)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer
por: Liu, Z, et al.
Publicado: (2014)

Opening the gateway to enhanced Eucalyptus
por: Shani, Ziv
Publicado: (2011)

Identification of genes and alleles influencing wood development in Eucalyptus
por: Southerton, Simon, et al.
Publicado: (2011)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Cojocaru, G, et al.
Publicado: (2014)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology
por: Jahn, L, et al.
Publicado: (2014)

PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis
por: Ravelli, A
Publicado: (2013)

Streamlining regulation of clinical trials – update on the Academy of Medical Sciences review and government’s response
por: Ford, Gary A
Publicado: (2011)

Patient reported outcomes: past, present, and future
por: Scott, Jane A
Publicado: (2011)

Using biomarkers prospectively in adaptive clinical trials
por: Berry, Donald A
Publicado: (2011)

Human papilloma viruses
por: Galloway, Denise A
Publicado: (2012)

De novo mutations in mental retardation
por: Veltman, Joris A
Publicado: (2011)

Viruses: a vast reservoir of genetic diversity and driver of global processes
por: Suttle, Curtis A
Publicado: (2009)

Integrating Casemix system in to the Philippine social health insurance
por: Gool, Maria Josefina A
Publicado: (2012)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

Development of ICD 11: changes and challenges
por: Zafar, A, et al.
Publicado: (2012)

S77. Proffered paper: In vitro induced response patterns of antileukemic T-cells – characterization by combination of functional assays, spectratyping and next generation sequencing
por: Reuther, S, et al.
Publicado: (2014)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

S48. Biomarker development for ipilimumab and prostate GVAX treatment
por: de Gruijl, T, et al.
Publicado: (2014)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

Hemicrania continua and unilateral headaches: are they still together in the IHS classification?
por: Antonaci, Fabio, et al.
Publicado: (2015)

Skin microbiome in health and disease
por: Segre, Julie A, et al.
Publicado: (2010)

Biochemical and virological analysis of the preference for the K65R multi-resistance nucleoside mutation in subtype C viruses
por: Wainberg, Mark A, et al.
Publicado: (2009)

Comparative analysis of the vaginal microbiome in health and disease
por: White, Bryan A, et al.
Publicado: (2011)

Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4(+)T lymphocytes, a transcriptome analysis
por: Mariani, Samanta A, et al.
Publicado: (2009)

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
por: Ward, Steve A, et al.
Publicado: (2010)

Genomic variation and adaptation in Africa: implications for human evolutionary history and disease
por: Tishkoff, Sarah A, et al.
Publicado: (2010)

Structure function analysis of P. falciparum VAR2CSA
por: Dahlbäck, Madeleine, et al.
Publicado: (2010)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

Personalized oncogenomics
por: Jones, Steven JM, et al.
Publicado: (2010)

Reconstructing sex chromosome evolution
por: Page, David C, et al.
Publicado: (2010)

Potential inflammatory consequences in HIV controllers
por: Hunt, Peter W, et al.
Publicado: (2010)

Deciphering the genetic basis of common diseases by integrated functional annotation of common and rare variants
por: Harismendy, Olivier, et al.
Publicado: (2010)

Novel vaccine and gene therapy approaches against HIV-AIDS
por: Das, A, et al.
Publicado: (2009)

Tracking genes and finding mutations: finding genes for complex traits in the domestic dog (Canis familiaris)
por: Ostrander, Elaine A, et al.
Publicado: (2010)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3bq7pim5nf8hnt2p9eg3jfecaa